NE

Natarajan Essakimuthu

Active Director Director DIN 08618048
DIN 08618048 First appointment Oct 2019 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Oct 2019
Shareholding value •••• Premium profile

About Natarajan Essakimuthu

Data last updated:

Natarajan Essakimuthu is a Director at Serastrands Biotherapeutics Private Limited (since 2019), Director at Sprygen Biotherapeutics Private Limited (since 2020) and Director at Significant Tempus Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Life Sciences, Research & Development and Information Technology. The largest current company by reported revenue is Serastrands Biotherapeutics Private Limited at ₹84,090 (FY 2024).

DIN 08618048
Primary Designation Director
Industry Life Sciences
First Appointment 29 Oct 2019
Oldest Company Age 8 yrs
Largest company Serastrands Biotherapeutics Private Limited · ₹84,090 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20192019₹84,090 (FY 2024)Active
Director10 Jan 20202020Active
Significant Tempus Private Limited U01411TN2025PTC180514
Director14 May 20252025Active
Additional Director04 May 20202018Active

Directorship timeline

Open interactive timeline →
Significant Tempus Private Limited
Revenup Ai Technologies Private Limited
Serastrands Biotherapeutics Private Limited
Sprygen Biotherapeutics Private Limited
Premium access

Shareholding and investment profile for Natarajan Essakimuthu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Natarajan Essakimuthu

Natarajan Essakimuthu currently holds 4 directorships: Serastrands Biotherapeutics Private Limited (Director, since 29 Oct 2019, revenue ₹84,090 (FY 2024)); Sprygen Biotherapeutics Private Limited (Director, since 10 Jan 2020); Significant Tempus Private Limited (Director, since 14 May 2025); Revenup Ai Technologies Private Limited (Additional Director, since 04 May 2020).

Natarajan Essakimuthu was first appointed on 29 Oct 2019 as Director at Serastrands Biotherapeutics Private Limited. The most recent appointment on record is 14 May 2025 at Significant Tempus Private Limited.

The current boards of Natarajan Essakimuthu's companies include Sujatha Shrinivas (Serastrands Biotherapeutics Private Limited), Shivakumar Ranganathan (Significant Tempus Private Limited), Sengamalai Lavanya (Revenup Ai Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available